External Neuromodulation Market
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global External Neuromodulation Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Transcutaneous Electrical Nerve Stimulation
1.2.3 Transcranial Magnetic Stimulation
1.2.4 Respiratory Electrical Stimulation
1.3 Market by Application
1.3.1 Global External Neuromodulation Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Spinal Cord Stimulation
1.3.3 Deep Brain Stimulation
1.3.4 Sacral Nerve Stimulation
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global External Neuromodulation Market Perspective (2017-2028)
2.2 External Neuromodulation Growth Trends by Region
2.2.1 External Neuromodulation Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 External Neuromodulation Historic Market Size by Region (2017-2022)
2.2.3 External Neuromodulation Forecasted Market Size by Region (2023-2028)
2.3 External Neuromodulation Market Dynamics
2.3.1 External Neuromodulation Industry Trends
2.3.2 External Neuromodulation Market Drivers
2.3.3 External Neuromodulation Market Challenges
2.3.4 External Neuromodulation Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top External Neuromodulation Players by Revenue
3.1.1 Global Top External Neuromodulation Players by Revenue (2017-2022)
3.1.2 Global External Neuromodulation Revenue Market Share by Players (2017-2022)
3.2 Global External Neuromodulation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by External Neuromodulation Revenue
3.4 Global External Neuromodulation Market Concentration Ratio
3.4.1 Global External Neuromodulation Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by External Neuromodulation Revenue in 2021
3.5 External Neuromodulation Key Players Head office and Area Served
3.6 Key Players External Neuromodulation Product Solution and Service
3.7 Date of Enter into External Neuromodulation Market
3.8 Mergers & Acquisitions, Expansion Plans
4 External Neuromodulation Breakdown Data by Type
4.1 Global External Neuromodulation Historic Market Size by Type (2017-2022)
4.2 Global External Neuromodulation Forecasted Market Size by Type (2023-2028)
5 External Neuromodulation Breakdown Data by Application
5.1 Global External Neuromodulation Historic Market Size by Application (2017-2022)
5.2 Global External Neuromodulation Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America External Neuromodulation Market Size (2017-2028)
6.2 North America External Neuromodulation Market Size by Country (2017-2022)
6.3 North America External Neuromodulation Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe External Neuromodulation Market Size (2017-2028)
7.2 Europe External Neuromodulation Market Size by Country (2017-2022)
7.3 Europe External Neuromodulation Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific External Neuromodulation Market Size (2017-2028)
8.2 Asia-Pacific External Neuromodulation Market Size by Country (2017-2022)
8.3 Asia-Pacific External Neuromodulation Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America External Neuromodulation Market Size (2017-2028)
9.2 Latin America External Neuromodulation Market Size by Country (2017-2022)
9.3 Latin America External Neuromodulation Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa External Neuromodulation Market Size (2017-2028)
10.2 Middle East & Africa External Neuromodulation Market Size by Country (2017-2022)
10.3 Middle East & Africa External Neuromodulation Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Medtronic, Inc. (US)
11.1.1 Medtronic, Inc. (US) Company Detail
11.1.2 Medtronic, Inc. (US) Business Overview
11.1.3 Medtronic, Inc. (US) External Neuromodulation Introduction
11.1.4 Medtronic, Inc. (US) Revenue in External Neuromodulation Business (2017-2022)
11.1.5 Medtronic, Inc. (US) Recent Development
11.2 Boston Scientific Corporation (US)
11.2.1 Boston Scientific Corporation (US) Company Detail
11.2.2 Boston Scientific Corporation (US) Business Overview
11.2.3 Boston Scientific Corporation (US) External Neuromodulation Introduction
11.2.4 Boston Scientific Corporation (US) Revenue in External Neuromodulation Business (2017-2022)
11.2.5 Boston Scientific Corporation (US) Recent Development
11.3 St. Jude Medical, Inc. (US)
11.3.1 St. Jude Medical, Inc. (US) Company Detail
11.3.2 St. Jude Medical, Inc. (US) Business Overview
11.3.3 St. Jude Medical, Inc. (US) External Neuromodulation Introduction
11.3.4 St. Jude Medical, Inc. (US) Revenue in External Neuromodulation Business (2017-2022)
11.3.5 St. Jude Medical, Inc. (US) Recent Development
11.4 Synapse Biomedical, Inc. (US)
11.4.1 Synapse Biomedical, Inc. (US) Company Detail
11.4.2 Synapse Biomedical, Inc. (US) Business Overview
11.4.3 Synapse Biomedical, Inc. (US) External Neuromodulation Introduction
11.4.4 Synapse Biomedical, Inc. (US) Revenue in External Neuromodulation Business (2017-2022)
11.4.5 Synapse Biomedical, Inc. (US) Recent Development
11.5 Nevro Corporation (US)
11.5.1 Nevro Corporation (US) Company Detail
11.5.2 Nevro Corporation (US) Business Overview
11.5.3 Nevro Corporation (US) External Neuromodulation Introduction
11.5.4 Nevro Corporation (US) Revenue in External Neuromodulation Business (2017-2022)
11.5.5 Nevro Corporation (US) Recent Development
11.6 Neurosigma, Inc. (US)
11.6.1 Neurosigma, Inc. (US) Company Detail
11.6.2 Neurosigma, Inc. (US) Business Overview
11.6.3 Neurosigma, Inc. (US) External Neuromodulation Introduction
11.6.4 Neurosigma, Inc. (US) Revenue in External Neuromodulation Business (2017-2022)
11.6.5 Neurosigma, Inc. (US) Recent Development
11.7 Neuropace, Inc. (US)
11.7.1 Neuropace, Inc. (US) Company Detail
11.7.2 Neuropace, Inc. (US) Business Overview
11.7.3 Neuropace, Inc. (US) External Neuromodulation Introduction
11.7.4 Neuropace, Inc. (US) Revenue in External Neuromodulation Business (2017-2022)
11.7.5 Neuropace, Inc. (US) Recent Development
11.8 Neuronetics, Inc. (US)
11.8.1 Neuronetics, Inc. (US) Company Detail
11.8.2 Neuronetics, Inc. (US) Business Overview
11.8.3 Neuronetics, Inc. (US) External Neuromodulation Introduction
11.8.4 Neuronetics, Inc. (US) Revenue in External Neuromodulation Business (2017-2022)
11.8.5 Neuronetics, Inc. (US) Recent Development
11.9 Cyberonics, Inc. (US)
11.9.1 Cyberonics, Inc. (US) Company Detail
11.9.2 Cyberonics, Inc. (US) Business Overview
11.9.3 Cyberonics, Inc. (US) External Neuromodulation Introduction
11.9.4 Cyberonics, Inc. (US) Revenue in External Neuromodulation Business (2017-2022)
11.9.5 Cyberonics, Inc. (US) Recent Development
11.10 BioControl Medical (Israel)
11.10.1 BioControl Medical (Israel) Company Detail
11.10.2 BioControl Medical (Israel) Business Overview
11.10.3 BioControl Medical (Israel) External Neuromodulation Introduction
11.10.4 BioControl Medical (Israel) Revenue in External Neuromodulation Business (2017-2022)
11.10.5 BioControl Medical (Israel) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global External Neuromodulation Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Transcutaneous Electrical Nerve Stimulation
Table 3. Key Players of Transcranial Magnetic Stimulation
Table 4. Key Players of Respiratory Electrical Stimulation
Table 5. Global External Neuromodulation Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global External Neuromodulation Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global External Neuromodulation Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global External Neuromodulation Market Share by Region (2017-2022)
Table 9. Global External Neuromodulation Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global External Neuromodulation Market Share by Region (2023-2028)
Table 11. External Neuromodulation Market Trends
Table 12. External Neuromodulation Market Drivers
Table 13. External Neuromodulation Market Challenges
Table 14. External Neuromodulation Market Restraints
Table 15. Global External Neuromodulation Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global External Neuromodulation Market Share by Players (2017-2022)
Table 17. Global Top External Neuromodulation Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in External Neuromodulation as of 2021)
Table 18. Ranking of Global Top External Neuromodulation Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by External Neuromodulation Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players External Neuromodulation Product Solution and Service
Table 22. Date of Enter into External Neuromodulation Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global External Neuromodulation Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global External Neuromodulation Revenue Market Share by Type (2017-2022)
Table 26. Global External Neuromodulation Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global External Neuromodulation Revenue Market Share by Type (2023-2028)
Table 28. Global External Neuromodulation Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global External Neuromodulation Revenue Market Share by Application (2017-2022)
Table 30. Global External Neuromodulation Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global External Neuromodulation Revenue Market Share by Application (2023-2028)
Table 32. North America External Neuromodulation Market Size by Country (2017-2022) & (US$ Million)
Table 33. North America External Neuromodulation Market Size by Country (2023-2028) & (US$ Million)
Table 34. Europe External Neuromodulation Market Size by Country (2017-2022) & (US$ Million)
Table 35. Europe External Neuromodulation Market Size by Country (2023-2028) & (US$ Million)
Table 36. Asia-Pacific External Neuromodulation Market Size by Region (2017-2022) & (US$ Million)
Table 37. Asia-Pacific External Neuromodulation Market Size by Region (2023-2028) & (US$ Million)
Table 38. Latin America External Neuromodulation Market Size by Country (2017-2022) & (US$ Million)
Table 39. Latin America External Neuromodulation Market Size by Country (2023-2028) & (US$ Million)
Table 40. Middle East & Africa External Neuromodulation Market Size by Country (2017-2022) & (US$ Million)
Table 41. Middle East & Africa External Neuromodulation Market Size by Country (2023-2028) & (US$ Million)
Table 42. Medtronic, Inc. (US) Company Detail
Table 43. Medtronic, Inc. (US) Business Overview
Table 44. Medtronic, Inc. (US) External Neuromodulation Product
Table 45. Medtronic, Inc. (US) Revenue in External Neuromodulation Business (2017-2022) & (US$ Million)
Table 46. Medtronic, Inc. (US) Recent Development
Table 47. Boston Scientific Corporation (US) Company Detail
Table 48. Boston Scientific Corporation (US) Business Overview
Table 49. Boston Scientific Corporation (US) External Neuromodulation Product
Table 50. Boston Scientific Corporation (US) Revenue in External Neuromodulation Business (2017-2022) & (US$ Million)
Table 51. Boston Scientific Corporation (US) Recent Development
Table 52. St. Jude Medical, Inc. (US) Company Detail
Table 53. St. Jude Medical, Inc. (US) Business Overview
Table 54. St. Jude Medical, Inc. (US) External Neuromodulation Product
Table 55. St. Jude Medical, Inc. (US) Revenue in External Neuromodulation Business (2017-2022) & (US$ Million)
Table 56. St. Jude Medical, Inc. (US) Recent Development
Table 57. Synapse Biomedical, Inc. (US) Company Detail
Table 58. Synapse Biomedical, Inc. (US) Business Overview
Table 59. Synapse Biomedical, Inc. (US) External Neuromodulation Product
Table 60. Synapse Biomedical, Inc. (US) Revenue in External Neuromodulation Business (2017-2022) & (US$ Million)
Table 61. Synapse Biomedical, Inc. (US) Recent Development
Table 62. Nevro Corporation (US) Company Detail
Table 63. Nevro Corporation (US) Business Overview
Table 64. Nevro Corporation (US) External Neuromodulation Product
Table 65. Nevro Corporation (US) Revenue in External Neuromodulation Business (2017-2022) & (US$ Million)
Table 66. Nevro Corporation (US) Recent Development
Table 67. Neurosigma, Inc. (US) Company Detail
Table 68. Neurosigma, Inc. (US) Business Overview
Table 69. Neurosigma, Inc. (US) External Neuromodulation Product
Table 70. Neurosigma, Inc. (US) Revenue in External Neuromodulation Business (2017-2022) & (US$ Million)
Table 71. Neurosigma, Inc. (US) Recent Development
Table 72. Neuropace, Inc. (US) Company Detail
Table 73. Neuropace, Inc. (US) Business Overview
Table 74. Neuropace, Inc. (US) External Neuromodulation Product
Table 75. Neuropace, Inc. (US) Revenue in External Neuromodulation Business (2017-2022) & (US$ Million)
Table 76. Neuropace, Inc. (US) Recent Development
Table 77. Neuronetics, Inc. (US) Company Detail
Table 78. Neuronetics, Inc. (US) Business Overview
Table 79. Neuronetics, Inc. (US) External Neuromodulation Product
Table 80. Neuronetics, Inc. (US) Revenue in External Neuromodulation Business (2017-2022) & (US$ Million)
Table 81. Neuronetics, Inc. (US) Recent Development
Table 82. Cyberonics, Inc. (US) Company Detail
Table 83. Cyberonics, Inc. (US) Business Overview
Table 84. Cyberonics, Inc. (US) External Neuromodulation Product
Table 85. Cyberonics, Inc. (US) Revenue in External Neuromodulation Business (2017-2022) & (US$ Million)
Table 86. Cyberonics, Inc. (US) Recent Development
Table 87. BioControl Medical (Israel) Company Detail
Table 88. BioControl Medical (Israel) Business Overview
Table 89. BioControl Medical (Israel) External Neuromodulation Product
Table 90. BioControl Medical (Israel) Revenue in External Neuromodulation Business (2017-2022) & (US$ Million)
Table 91. BioControl Medical (Israel) Recent Development
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
List of Figures
Figure 1. Global External Neuromodulation Market Share by Type: 2021 VS 2028
Figure 2. Transcutaneous Electrical Nerve Stimulation Features
Figure 3. Transcranial Magnetic Stimulation Features
Figure 4. Respiratory Electrical Stimulation Features
Figure 5. Global External Neuromodulation Market Share by Application in 2021 & 2028
Figure 6. Spinal Cord Stimulation Case Studies
Figure 7. Deep Brain Stimulation Case Studies
Figure 8. Sacral Nerve Stimulation Case Studies
Figure 9. Others Case Studies
Figure 10. External Neuromodulation Report Years Considered
Figure 11. Global External Neuromodulation Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global External Neuromodulation Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global External Neuromodulation Market Share by Region: 2021 VS 2028
Figure 14. Global External Neuromodulation Market Share by Players in 2021
Figure 15. Global Top External Neuromodulation Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in External Neuromodulation as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by External Neuromodulation Revenue in 2021
Figure 17. North America External Neuromodulation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. North America External Neuromodulation Market Share by Country (2017-2028)
Figure 19. United States External Neuromodulation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada External Neuromodulation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe External Neuromodulation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe External Neuromodulation Market Share by Country (2017-2028)
Figure 23. Germany External Neuromodulation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. France External Neuromodulation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. U.K. External Neuromodulation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Italy External Neuromodulation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Russia External Neuromodulation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Nordic Countries External Neuromodulation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Asia-Pacific External Neuromodulation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific External Neuromodulation Market Share by Region (2017-2028)
Figure 31. China External Neuromodulation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Japan External Neuromodulation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. South Korea External Neuromodulation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Southeast Asia External Neuromodulation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. India External Neuromodulation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Australia External Neuromodulation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Latin America External Neuromodulation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Latin America External Neuromodulation Market Share by Country (2017-2028)
Figure 39. Mexico External Neuromodulation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Brazil External Neuromodulation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Middle East & Africa External Neuromodulation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Middle East & Africa External Neuromodulation Market Share by Country (2017-2028)
Figure 43. Turkey External Neuromodulation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Saudi Arabia External Neuromodulation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Medtronic, Inc. (US) Revenue Growth Rate in External Neuromodulation Business (2017-2022)
Figure 46. Boston Scientific Corporation (US) Revenue Growth Rate in External Neuromodulation Business (2017-2022)
Figure 47. St. Jude Medical, Inc. (US) Revenue Growth Rate in External Neuromodulation Business (2017-2022)
Figure 48. Synapse Biomedical, Inc. (US) Revenue Growth Rate in External Neuromodulation Business (2017-2022)
Figure 49. Nevro Corporation (US) Revenue Growth Rate in External Neuromodulation Business (2017-2022)
Figure 50. Neurosigma, Inc. (US) Revenue Growth Rate in External Neuromodulation Business (2017-2022)
Figure 51. Neuropace, Inc. (US) Revenue Growth Rate in External Neuromodulation Business (2017-2022)
Figure 52. Neuronetics, Inc. (US) Revenue Growth Rate in External Neuromodulation Business (2017-2022)
Figure 53. Cyberonics, Inc. (US) Revenue Growth Rate in External Neuromodulation Business (2017-2022)
Figure 54. BioControl Medical (Israel) Revenue Growth Rate in External Neuromodulation Business (2017-2022)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Industry Market Size
